Ex-CDC director weighs in on White House’s coronavirus timeline

0
2


The White House coronavirus task force has projected the coronavirus pandemic to go through June, possibly slowing down in July. Dr. Tom Frieden, who served as CDC Director during the Ebola and Zika outbreaks, weighs in on the latest pandemic models and how Americans can stay healthy during an appearance on “CBS This Morning.”

Related Links:

A group of moderately ill people were given hydroxychloroquine, which appeared to ease their symptoms quickly, but more research is needed.

Source: NYTCategory: American Health Authors: Tags: Coronavirus (2019-nCoV) Hydroxychloroquine (Drug) Drugs (Pharmaceuticals) Quarantines Shortages Autoimmune Diseases Pneumonia Immune System Malaria Schaffner, William your-feed-healthcare Source Type: news

A member of the Arkansas House said Wednesday he’s tested positive for the coronavirus and state health officials reported two more people have died from the outbreak.

Daniel J. IkensonSome people talk about trade as though it were an end in itself. It ’s not. Trade is a means to an end.We trade so that we can specialize. We specialize so that we can produce more. We produce more so that we can consume and save more. That is how we create wealth and raise living standards. Just like electricity or machinery or expertise, trade is a tool we use to leverage our physical, mental, and creative abilities to obtain more efficiently more of the things we need and want. When we remove barriers to trade, we create greater scope for specialization, which means we can produce more v…

Source: Cato-at-libertyCategory: American Health Authors: Source Type: blogs

Authors: Ventura CG, Roque FL, Sousa IQ, Lobo RD, Luders C
Abstract
INTRODUCTION: Chronic hemodialysis (HD) patients are considered to be at high risk for infection. Here, we describe the clinical outcomes of chronic HD patients with influenza A (H1N1) infection and the strategies adopted to control an outbreak of influenza A in a dialysis unit.
METHODS: Among a total of 62 chronic HD patients, H1N1 infection was identified in 12 (19.4%). Of the 32 staff members, four (12.5%) were found to be infected with the H1N1 virus. Outcomes included symptoms at presentation, comorbidities, occurrence of hypoxemia, hospit…

Telemedicine has not had the success story it had hoped to achieve. The method, involving remote health-related services such as monitoring, advice and education between doctors and patients online over a secure connection, promised to be at the forefront of the future of medicine. It promised to make state-of-the-art healthcare more accessible without the need to wait hours in line. 

However, the reality is that only a handful of countries and regions adopted the concept, but telemedicine remains merely a concept for many. In fact, a study showed that in the U.S. alone, 82 percent of consumers do not use such serv…

Source: The Medical FuturistCategory: Information Technology Authors: Tags: Future of Medicine Healthcare Design Telemedicine & Smartphones digital health technology telehealth covid covid19 Source Type: blogs

President Donald Trump’s declaration of a national emergency is designed to speed federal support to parts of America that are struggling to prepare for a coming surge of COVID-19 cases, unlocking $50 billion in aid, giving hospitals and doctors more freedom to handle a potential tsunami of sick patients and scrambling to make tests available. In a Rose Garden press conference Friday, Trump presented the emergency measures as proof that, “No nation is more prepared or more equipped to face down this crisis.”
But for epidemiologists, medical experts and current and former U.S. public health officials, the …

Source: TIME: HealthCategory: Consumer Health News Authors: Tags: Uncategorized COVID-19 Source Type: news

NEW BRUNSWICK, N.J., March 13, 2020 – Johnson &Johnson today announced that its Janssen Pharmaceutical Companies have entered a collaboration with the Beth Israel Deaconess Medical Center (BIDMC) to support the development of a preventive vaccine candidate for COVID-19. The parties have commenced preclinical testing of multiple vaccine prospects, with the aim to identify by the end of the month a COVID-19 vaccine candidate for clinical trials.Janssen is optimistic that, in collaboration with multiple global strategic partners, it can initiate a Phase 1 clinical study of a potential vaccine candidate by the end of…

Source: Johnson and JohnsonCategory: Pharmaceuticals Tags: Our Company Source Type: news

TTP, a technology company based in Melbourn, UK, is developing a handheld PCR (polymerase chain reaction) diagnostic device that can rapidly detect influenza viruses, and one day other viruses, in samples of nasal mucus. The company claims that the s…

Source: MedgadgetCategory: Medical Devices Authors: Tags: Diagnostics Exclusive Public Health Source Type: blogs

Source: Aspen Institute. Published: 2/11/2020.
In this one-hour, 22-minute panel discussion, experts with experience in the SARS, Ebola, and Zika outbreaks detail the emerging novel coronavirus (COVID-19) and the threat it poses. They discuss how bad it may get, how dangerous is it, and if the country is prepared for it.
(Video or Multimedia)

Pandemics are perversely democratic. They’re nasty, lethal and sneaky, but they don’t discriminate. No matter your age, ethnicity, religion, gender, or nation, you’re a part of the pathogenic constituency.
That shared vulnerability, and the resulting human collectivism—a universal response to a universal threat—is newly and vividly evident in the face of the now-global outbreak of the novel coronavirus known as 2019-nCoV. As of writing, there have been over 30,000 diagnosed cases and over 630 related deaths. A virus that emerged in a single city, Wuhan, China—indeed, in a single crowded …

Source: TIME: HealthCategory: Consumer Health News Authors: Tags: Uncategorized 2019-nCoV Infectious Disease Source Type: news



Source link